Cencora Inc (COR)

$366.03 +4.95 (1.37%)
Market Cap 70.24B
Revenue (ttm) 321.33B
Net Income (ttm) 1.55B
EPS (ttm) N/A
PE Ratio 21.98
Forward PE 20.43
Profit Margin 0.48%
Debt to Equity Ratio 3.78
Volume 919,400
Avg Vol 1,262,924
Day's Range N/A - N/A
Shares Out 194.53M
Stochastic %K 68%
Beta 0.68
Analysts Strong Sell
Price Target $408.07

Company Profile

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distr...

Industry: Medical Distribution
Sector: Healthcare
Phone: 610 727 7000
Address:
1 West First Avenue, Conshohocken, United States
PanicSeller8
PanicSeller8 Feb. 23 at 8:53 PM
$CAH $MCK $COR Overweight all these names. They print money and have stable demand no matter the economy.
0 · Reply
Knowledgeworthmore
Knowledgeworthmore Feb. 23 at 2:38 PM
$WGRX a lot investor don't aware of this baby $COR their business set up so good.
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 19 at 10:32 PM
$COR Share Price: $359.09 Contract Selected: Jun 18, 2026 $360 Calls Buy Zone: $19.21 – $23.73 Target Zone: $33.60 – $41.07 Potential Upside: 65% ROI Time to Expiration: 118 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Feb. 19 at 2:18 PM
$COR’s strategic move: What does the MWI-Covetrus merger mean for investors? 🤔 💼 Unlocks $1.25B upfront cash + $800M in preferred equity + $1.45B in common equity, strengthening balance sheet 🔗 Retains 34.3% stake in combined company for long-term upside 📈 MWI's integration with Covetrus boosts efficiency & innovation See how this deal positions COR for future growth 👉 https://www.zacks.com/stock/news/2871829/cors-mwi-animal-health-to-merge-with-covetrus-in-35-billion-deal?cid=sm-stocktwits-2-2871829-body-34180&ADID=SYND_STOCKTWITS_TWEET_2_2871829_BODY_34180
0 · Reply
ZacksResearch
ZacksResearch Feb. 19 at 1:18 PM
$COR makes a $3.5B move in animal health — strategic unlock or quiet power play? 🐾 Cencora is merging MWI Animal Health with Covetrus, retaining a 34.3% stake while unlocking capital and sharpening its focus on animal health growth. That’s not an exit — it’s a repositioning. Dig into what this deal could mean for shareholders 👉 https://www.zacks.com/stock/news/2871829/cors-mwi-animal-health-to-merge-with-covetrus-in-35-billion-deal?cid=sm-stocktwits-2-2871829-teaser-34165&ADID=SYND_STOCKTWITS_TWEET_2_2871829_TEASER_34165
0 · Reply
LandonCapital
LandonCapital Feb. 18 at 7:09 PM
$COR
0 · Reply
Sunny3999
Sunny3999 Feb. 18 at 5:19 PM
$PMN NEXT STOP $50 $CAH $CI $COR $MCK
0 · Reply
Estimize
Estimize Feb. 18 at 3:00 PM
Wall St is expecting 4.87 EPS for $COR Q2 [Reporting 05/06 BMO] http://www.estimize.com/intro/cor?chart=historical&metric_name=eps&utm_cont
0 · Reply
Moosedog97
Moosedog97 Feb. 18 at 2:42 PM
$COR selling MWI to $CVET
0 · Reply
Knowledgeworthmore
Knowledgeworthmore Feb. 18 at 1:06 PM
$WGRX this is one of those companies, it will sleep sleep but one day will skyrocket, i call this baby $COR
0 · Reply
Latest News on COR
Cencora's animal health unit to merge with Covetrus in $3.5 billion deal

Feb 18, 2026, 7:09 AM EST - 5 days ago

Cencora's animal health unit to merge with Covetrus in $3.5 billion deal

Covetrus and MWI Animal Health to Merge

Feb 18, 2026, 7:00 AM EST - 5 days ago

Covetrus and MWI Animal Health to Merge

Cencora Closes $3.0 Billion Senior Notes Offering

Feb 13, 2026, 4:15 PM EST - 10 days ago

Cencora Closes $3.0 Billion Senior Notes Offering

Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056

Feb 10, 2026, 5:15 PM EST - 13 days ago

Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056

Cencora, Inc. (COR) Q1 2026 Earnings Call Transcript

Feb 4, 2026, 1:10 PM EST - 19 days ago

Cencora, Inc. (COR) Q1 2026 Earnings Call Transcript

Cencora beats quarterly profit estimates on strong demand for specialty medicines

Feb 4, 2026, 8:20 AM EST - 19 days ago

Cencora beats quarterly profit estimates on strong demand for specialty medicines

Cencora Reports Fiscal 2026 First Quarter Results

Feb 4, 2026, 6:30 AM EST - 19 days ago

Cencora Reports Fiscal 2026 First Quarter Results

Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products

Jan 22, 2026, 9:00 AM EST - 4 weeks ago

Curant Rare Announces Collaboration with Cencora to Support Commercialization of Rare and Orphan Drug Products

Cencora Elects Ellen Cooper to Its Board of Directors

Jan 22, 2026, 7:30 AM EST - 4 weeks ago

Cencora Elects Ellen Cooper to Its Board of Directors

Cencora: High-Growth Specialty Services Firm Disguised As A Distributor

Jan 21, 2026, 8:06 AM EST - 4 weeks ago

Cencora: High-Growth Specialty Services Firm Disguised As A Distributor

Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 2:36 PM EST - 6 weeks ago

Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release

Jan 6, 2026, 4:30 PM EST - 6 weeks ago

Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release

Cencora to take majority control of OneOncology to expand cancer services

Dec 15, 2025, 7:11 AM EST - 2 months ago

Cencora to take majority control of OneOncology to expand cancer services

Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology

Dec 15, 2025, 7:00 AM EST - 2 months ago

Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology

Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

Dec 3, 2025, 7:30 AM EST - 2 months ago

Cencora Enhances Global Pharmaceutical Logistics Services, Cold Chain Capabilities

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 2, 2025, 3:33 PM EST - 2 months ago

Cencora, Inc. (COR) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 2, 2025, 12:53 PM EST - 2 months ago

Cencora, Inc. (COR) Presents at Evercore 8th Annual Healthcare Conference Transcript

Cencora: Earnings Visibility Driving Re-Rating Potential

Nov 7, 2025, 2:05 PM EST - 3 months ago

Cencora: Earnings Visibility Driving Re-Rating Potential

Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript

Nov 5, 2025, 4:01 PM EST - 3 months ago

Cencora, Inc. (COR) Q4 2025 Earnings Call Transcript

Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast

Nov 5, 2025, 7:44 AM EST - 3 months ago

Cencora to invest $1 billion on US drug distribution, posts upbeat 2026 forecast

Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain

Nov 5, 2025, 7:00 AM EST - 3 months ago

Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain

Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network

Nov 5, 2025, 7:00 AM EST - 3 months ago

Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

Nov 5, 2025, 6:30 AM EST - 3 months ago

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November

Nov 1, 2025, 11:15 PM EDT - 4 months ago

ADP, Snap-on Lead 14 Companies To Announce Annual Increases In First Half Of November

ABBV ADP AEP AIZ AOS ATO BDX

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

Oct 16, 2025, 9:00 AM EDT - 4 months ago

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

Oct 14, 2025, 12:47 PM EDT - 4 months ago

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

MCK WFC

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

Oct 6, 2025, 4:30 PM EDT - 5 months ago

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 10, 2025, 2:05 PM EDT - 5 months ago

Cencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Sep 9, 2025, 6:02 PM EDT - 5 months ago

Cencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 Transcript

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 5, 2025, 11:11 AM EDT - 6 months ago

Cencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Aug 27, 2025, 4:15 PM EDT - 6 months ago

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap

Aug 12, 2025, 2:31 PM EDT - 6 months ago

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap

Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Aug 8, 2025, 5:08 PM EDT - 7 months ago

Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy

Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript

Aug 6, 2025, 12:25 PM EDT - 7 months ago

Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript

Cencora raises annual profit forecast on strong demand for specialty drugs

Aug 6, 2025, 7:51 AM EDT - 7 months ago

Cencora raises annual profit forecast on strong demand for specialty drugs

Cencora Reports Fiscal 2025 Third Quarter Results

Aug 6, 2025, 6:30 AM EDT - 7 months ago

Cencora Reports Fiscal 2025 Third Quarter Results

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

Jul 3, 2025, 7:30 AM EDT - 8 months ago

Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

May 28, 2025, 7:30 AM EDT - 9 months ago

Cencora Elects Lori J. Ryerkerk to Its Board of Directors

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

May 16, 2025, 8:37 AM EDT - 10 months ago

Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

May 7, 2025, 2:06 PM EDT - 10 months ago

Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

May 7, 2025, 10:55 AM EDT - 10 months ago

Cencora, Inc. (COR) Q2 2025 Earnings Call Transcript

Cencora Reports Fiscal 2025 Second Quarter Results

May 7, 2025, 6:30 AM EDT - 10 months ago

Cencora Reports Fiscal 2025 Second Quarter Results

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 11 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

CVS MCK PM

These 15 stocks are the most profitable companies in the S&P 500

Mar 31, 2025, 7:35 AM EDT - 11 months ago

These 15 stocks are the most profitable companies in the S&P 500

AAPL ABBV AON BA CL CLX DVA

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Mar 28, 2025, 7:00 AM EDT - 11 months ago

Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Feb 26, 2025, 11:00 AM EST - 1 year ago

Cencora: Higher Potential Returns After Reduced Walgreens Stake

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Feb 6, 2025, 8:37 PM EST - 1 year ago

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

Feb 6, 2025, 8:30 PM EST - 1 year ago

Walgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of Proceeds

WBA

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Feb 6, 2025, 8:30 AM EST - 1 year ago

Cencora Reinforces Efforts to Strengthen Pharmaceutical Supply Chain with Expansion of Drug Shortages Mitigation Program

Cencora (COR) Q1 2025 Earnings Call Transcript

Feb 5, 2025, 11:40 AM EST - 1 year ago

Cencora (COR) Q1 2025 Earnings Call Transcript

PanicSeller8
PanicSeller8 Feb. 23 at 8:53 PM
$CAH $MCK $COR Overweight all these names. They print money and have stable demand no matter the economy.
0 · Reply
Knowledgeworthmore
Knowledgeworthmore Feb. 23 at 2:38 PM
$WGRX a lot investor don't aware of this baby $COR their business set up so good.
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 19 at 10:32 PM
$COR Share Price: $359.09 Contract Selected: Jun 18, 2026 $360 Calls Buy Zone: $19.21 – $23.73 Target Zone: $33.60 – $41.07 Potential Upside: 65% ROI Time to Expiration: 118 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
ZacksResearch
ZacksResearch Feb. 19 at 2:18 PM
$COR’s strategic move: What does the MWI-Covetrus merger mean for investors? 🤔 💼 Unlocks $1.25B upfront cash + $800M in preferred equity + $1.45B in common equity, strengthening balance sheet 🔗 Retains 34.3% stake in combined company for long-term upside 📈 MWI's integration with Covetrus boosts efficiency & innovation See how this deal positions COR for future growth 👉 https://www.zacks.com/stock/news/2871829/cors-mwi-animal-health-to-merge-with-covetrus-in-35-billion-deal?cid=sm-stocktwits-2-2871829-body-34180&ADID=SYND_STOCKTWITS_TWEET_2_2871829_BODY_34180
0 · Reply
ZacksResearch
ZacksResearch Feb. 19 at 1:18 PM
$COR makes a $3.5B move in animal health — strategic unlock or quiet power play? 🐾 Cencora is merging MWI Animal Health with Covetrus, retaining a 34.3% stake while unlocking capital and sharpening its focus on animal health growth. That’s not an exit — it’s a repositioning. Dig into what this deal could mean for shareholders 👉 https://www.zacks.com/stock/news/2871829/cors-mwi-animal-health-to-merge-with-covetrus-in-35-billion-deal?cid=sm-stocktwits-2-2871829-teaser-34165&ADID=SYND_STOCKTWITS_TWEET_2_2871829_TEASER_34165
0 · Reply
LandonCapital
LandonCapital Feb. 18 at 7:09 PM
$COR
0 · Reply
Sunny3999
Sunny3999 Feb. 18 at 5:19 PM
$PMN NEXT STOP $50 $CAH $CI $COR $MCK
0 · Reply
Estimize
Estimize Feb. 18 at 3:00 PM
Wall St is expecting 4.87 EPS for $COR Q2 [Reporting 05/06 BMO] http://www.estimize.com/intro/cor?chart=historical&metric_name=eps&utm_cont
0 · Reply
Moosedog97
Moosedog97 Feb. 18 at 2:42 PM
$COR selling MWI to $CVET
0 · Reply
Knowledgeworthmore
Knowledgeworthmore Feb. 18 at 1:06 PM
$WGRX this is one of those companies, it will sleep sleep but one day will skyrocket, i call this baby $COR
0 · Reply
Knowledgeworthmore
Knowledgeworthmore Feb. 15 at 5:16 AM
$OTLK right now im not worried about fda, if we have good market data from Europe, thats mean we are going to have good business with chines partner, maybe new comers dont know yet $OTLK have partnership with one of the china company and with with $COR
0 · Reply
CrazyChief
CrazyChief Feb. 14 at 6:14 PM
$OTLK $COR
0 · Reply
PanicSeller8
PanicSeller8 Feb. 12 at 7:10 PM
$MCK $CAH $COR Getting grilled on Capitol Hill but will add when the dust settles end of day.
0 · Reply
erevnon
erevnon Feb. 10 at 2:39 PM
Wells Fargo maintains Cencora $COR at Overweight and raises the price target from $405 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
rottieluvr3
rottieluvr3 Feb. 5 at 9:14 PM
$COR What the hell is happening AH????
0 · Reply
topstockalerts
topstockalerts Feb. 5 at 3:32 PM
$COR Curling back up with buyers stepping in 📈. Momentum is building and price is starting to respond. This could be the start of another move.
0 · Reply
ZacksResearch
ZacksResearch Feb. 4 at 5:58 PM
$COR Q1 beat — but why the 5.3% pre-market drop? 🤔 Despite a solid EPS beat and a 5.5% revenue increase, shares slid as operational pressures and higher expenses might be weighing on investor sentiment, even though FY26 guidance exceeded expectations. Full analysis here 👉 https://www.zacks.com/stock/news/2829152/cencora-stock-down-despite-q1-earnings-beat-gross-margin-improves?cid=sm-stocktwits-2-2829152-body-32013&ADID=SYND_STOCKTWITS_TWEET_2_2829152_BODY_32013
0 · Reply
ZacksResearch
ZacksResearch Feb. 4 at 4:58 PM
Earnings beat… yet the stock drops? $COR has investors scratching their heads 🤔📉 Cencora posted a Q1 EPS beat with revenues matching estimates, gross margins improved, and fiscal 2026 growth guidance was raised — but shares still slipped. See what the market might be missing here 👉 https://www.zacks.com/stock/news/2829152/cencora-stock-down-despite-q1-earnings-beat-gross-margin-improves?cid=sm-stocktwits-2-2829152-teaser-31996&ADID=SYND_STOCKTWITS_TWEET_2_2829152_TEASER_31996
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 4 at 11:40 AM
$COR Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $2.88 up 14.29% YoY • Reported revenue of $85.93B up 5.45% YoY • Cencora raised its adjusted operating income guidance to 11.5% to 13.5% growth for fiscal year 2026, while reaffirming adjusted diluted EPS guidance at $17.45 to $17.75.
0 · Reply
OptionRunners
OptionRunners Feb. 3 at 8:41 PM
$COR big 2027 call buyer again ahead of earnings in the morning. Had one last week as well
0 · Reply
Sunny3999
Sunny3999 Feb. 3 at 4:16 PM
$PMN MCAP of $35 Million for an Alzheimer solution with Fast Track designation and DSMB approval without ARIA! This is a 1 billion MCAP in the making easily a 10 bagger $CAH $CI $COR $MCK
0 · Reply
Sunny3999
Sunny3999 Feb. 3 at 4:13 PM
$PMN MCAP of $35 Million for an Alzheimer solution with Fast Track designation and DSMB approval without ARIA! This is a 1 billion MCAP in the making easily a 10 bagger $CAH $CI $COR $MCK
0 · Reply